Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"advancing ongoing licensing efforts that are already well underway"

No doubt that that's some pretty positive language. May as well finish and link that 5/29 quote:
“Both Brilacidin and Kevetrin are Platform drug candidates with multiple therapeutic applications given unique mechanisms of action and properties. We feel strongly that these drug candidates hold tremendous treatment potential for improving the lives of countless patients and look forward to continuing to evaluate them in clinical trials.”
http://www.ipharminc.com/press-release/2019/5/29/innovation-pharmaceuticals-to-attend-2019-bio-international-convention-june-3-6

From the 10-Q:
"The Company expects to seek to obtain additional funding through business development activities (i.e. licensing and partnerships) and future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available."
https://www.sec.gov/Archives/edgar/data/1355250/000147793219002567/ipix_10q.htm
That sounds a little less positive.


That's why this old saying lives on: "Judge a man not by his words, but by his deeds."
Works for companies too. We've heard the words.